This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences. Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU, it gives me great pleasure in welcoming all of you to the Virtue Insight’s 3rd Annual Pharma Pricing, Reimbursement & Market Access 2020. I wish and pray that all our efforts will be beneficial to our industry and to our country at large.
An impressive list of speakers already confirmed from major organisation such as Pfizer, Lonza, AstraZeneca, Bayer, SunPharma, Ferring Pharma, Supernus Pharma, Sobi, Seacross Pharma, Beigene, ConsenSys Health, National Alliance of Healthcare Purchaser Coalitions, Seqirus, Cutaneous Lymphoma Foundation, AppliedVR, EVERSANA, Health Economics and Outcomes Research, McDermott Will & Emery, Connect 4 Strategies, & more will be added soon.